{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T15:15:32Z","timestamp":1786461332240,"version":"build-2736575974"},"reference-count":179,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,26]],"date-time":"2023-10-26T00:00:00Z","timestamp":1698278400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005851","name":"Shahid Beheshti University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005851","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.biopha.2023.115805","type":"journal-article","created":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T09:36:20Z","timestamp":1698744980000},"page":"115805","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Therapeutic potentials of cannabidiol: Focus on the Nrf2 signaling pathway"],"prefix":"10.1016","volume":"168","author":[{"given":"Marjan","family":"Talebi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Mehdi","family":"Sadoughi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Abdulmajid","family":"Ayatollahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaheh","family":"Ainy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roghayeh","family":"Kiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Zali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MirMohammad","family":"Miri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.biopha.2023.115805_bib1","article-title":"Prosopis plant chemical composition and pharmacological attributes: targeting clinical studies from preclinical evidence","volume":"9","author":"Sharifi-Rad","year":"2019","journal-title":"Biomolecules [Internet]"},{"issue":"8","key":"10.1016\/j.biopha.2023.115805_bib2","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/j.biotechadv.2015.08.001","article-title":"Discovery and resupply of pharmacologically active plant-derived natural products: a review","volume":"33","author":"Atanasov","year":"2015","journal-title":"Biotechnol. Adv. [Internet]"},{"key":"10.1016\/j.biopha.2023.115805_bib3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41573-020-00114-z","article-title":"Natural products in drug discovery: advances and opportunities","volume":"20","author":"Atanasov","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"issue":"7","key":"10.1016\/j.biopha.2023.115805_bib4","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.fitote.2010.05.017","article-title":"Two new lathyrane type diterpenoids from Euphorbia aellenii","volume":"81","author":"Ayatollahi","year":"2010","journal-title":"Fitoterapia [Internet]"},{"issue":"1","key":"10.1016\/j.biopha.2023.115805_bib5","first-page":"97","article-title":"Cannabis sativa L.: a review on traditional uses, botany, phytochemistry, and pharmacological aspects","volume":"8","author":"Chaachouay","year":"2023","journal-title":"Tradit. Integr. Med. [Internet]"},{"issue":"2","key":"10.1016\/j.biopha.2023.115805_bib6","doi-asserted-by":"crossref","DOI":"10.1111\/adb.12772","article-title":"Novel role for cannabidiol in circadian clock function","volume":"25","author":"Bifulco","year":"2020","journal-title":"Addict. Biol."},{"key":"10.1016\/j.biopha.2023.115805_bib7","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.3390\/molecules28073271","article-title":"The polypharmacological effects of cannabidiol","volume":"28","author":"Castillo-Arellano","year":"2023","journal-title":"Molecules"},{"issue":"23","key":"10.1016\/j.biopha.2023.115805_bib8","article-title":"Cannabis sativa Cannabinoids as functional ingredients in snack foods-historical and developmental aspects","volume":"11","author":"Kr\u00fcger","year":"2022","journal-title":"Plants (Basel) [Internet]"},{"key":"10.1016\/j.biopha.2023.115805_bib9","article-title":"Potential effects of cannabinoids on audiovestibular function: a narrative review","volume":"13","author":"Guerra","year":"2022","journal-title":"Front Pharm. [Internet]"},{"issue":"17","key":"10.1016\/j.biopha.2023.115805_bib10","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1001\/jama.2017.11909","article-title":"Labeling accuracy of cannabidiol extracts sold online","volume":"318","author":"Bonn-Miller","year":"2017","journal-title":"JAMA - J. Am. Med. Assoc."},{"key":"10.1016\/j.biopha.2023.115805_bib11","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ypmed.2017.07.008","article-title":"Cannabis use, attitudes, and legal status in the U.S.: a review","volume":"104","author":"Carliner","year":"2017","journal-title":"Prev. Med. (Balt. ) [Internet]"},{"key":"10.1016\/j.biopha.2023.115805_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuron.2022.12.022","article-title":"THC and CBD: similarities and differences between siblings","author":"Stella","year":"2023","journal-title":"Neuron"},{"key":"10.1016\/j.biopha.2023.115805_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2022.173492","article-title":"Implications of the endocannabinoid system and the therapeutic action of cannabinoids in autism spectrum disorder: a literature review","volume":"221","author":"de Camargo","year":"2022","journal-title":"Pharm. Biochem. Behav."},{"issue":"3","key":"10.1016\/j.biopha.2023.115805_bib14","doi-asserted-by":"crossref","first-page":"993","DOI":"10.21873\/anticanres.16243","article-title":"Phytocannabinoids in triple negative breast cancer treatment: current knowledge and future insights","volume":"43","author":"Bimonte","year":"2023","journal-title":"Anticancer Res. [Internet]"},{"issue":"12","key":"10.1016\/j.biopha.2023.115805_bib15","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1016\/j.clinthera.2022.10.003","article-title":"A systematic review of medical cannabinoids dosing in human","volume":"44","author":"Campos","year":"2022","journal-title":"Clin. Ther."},{"issue":"3","key":"10.1016\/j.biopha.2023.115805_bib16","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.tips.2016.12.004","article-title":"Cannabidiol claims and misconceptions","volume":"38","author":"Russo","year":"2017","journal-title":"Trends Pharm. Sci."},{"key":"10.1016\/j.biopha.2023.115805_bib17","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/978-3-030-61663-2_2","article-title":"Synthetic and natural derivatives of cannabidiol","volume":"1297","author":"Morales","year":"2021","journal-title":"Adv. Exp. Med. Biol."},{"issue":"11","key":"10.1016\/j.biopha.2023.115805_bib18","doi-asserted-by":"crossref","first-page":"14083","DOI":"10.1096\/fj.202000975R","article-title":"A molecular basis for the anti-inflammatory and anti-fibrosis properties of cannabidiol","volume":"34","author":"Sunda","year":"2020","journal-title":"FASEB J. [Internet]"},{"key":"10.1016\/j.biopha.2023.115805_bib19","article-title":"The cannabidiol and marijuana research expansion act: promotion of scientific knowledge to prevent a national health crisis","volume":"14","author":"Purcell","year":"2022","journal-title":"Lancet Reg. Health Am. [Internet]"},{"issue":"4","key":"10.1016\/j.biopha.2023.115805_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24043125","article-title":"Effects of Cannabidiol on innate immunity: experimental evidence and clinical relevance","volume":"24","author":"Martini","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"21","key":"10.1016\/j.biopha.2023.115805_bib21","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1056\/NEJMoa1611618","article-title":"Trial of cannabidiol for drug-resistant seizures in the dravet syndrome","volume":"376","author":"Devinsky","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.biopha.2023.115805_bib22","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/s41573-018-0008-x","article-title":"Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases","volume":"18","author":"Cuadrado","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.biopha.2023.115805_bib23","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.freeradbiomed.2020.03.023","article-title":"Beyond repression of Nrf2: an update on Keap1","volume":"157","author":"Kopacz","year":"2020","journal-title":"Free Radic. Biol. Med."},{"issue":"5","key":"10.1016\/j.biopha.2023.115805_bib24","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1002\/med.21396","article-title":"The Keap1\u2013Nrf2\u2013ARE pathway as a potential preventive and therapeutic target: an update","volume":"36","author":"Lu","year":"2016","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.biopha.2023.115805_bib25","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.freeradbiomed.2013.02.008","article-title":"Regulation of Nrf2 - an update","volume":"66","author":"Niture","year":"2014","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.biopha.2023.115805_bib26","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1146\/annurev-pharmtox-052220-104025","article-title":"Targeting NRF2 and its downstream processes: opportunities and challenges","volume":"62","author":"Torrente","year":"2022","journal-title":"Annu. Rev. Pharm. Toxicol."},{"key":"10.1016\/j.biopha.2023.115805_bib27","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.3390\/molecules26113157","article-title":"Roles of Nrf2 in gastric cancer: targeting for therapeutic strategies","volume":"26","author":"Farkhondeh","year":"2021","journal-title":"Molecules"},{"issue":"21","key":"10.1016\/j.biopha.2023.115805_bib28","doi-asserted-by":"crossref","first-page":"12137","DOI":"10.1021\/acs.jmedchem.0c00724","article-title":"The essential medicinal chemistry of cannabidiol (CBD)","volume":"63","author":"Nelson","year":"2020","journal-title":"J. Med. Chem. [Internet]"},{"issue":"12","key":"10.1016\/j.biopha.2023.115805_bib29","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.tem.2022.08.003","article-title":"Cannabinoids and terpenes for diabetes mellitus and its complications: from mechanisms to new therapies","volume":"33","author":"Ghasemi-Gojani","year":"2022","journal-title":"Trends Endocrinol. Metab."},{"issue":"June","key":"10.1016\/j.biopha.2023.115805_bib30","article-title":"An overview on medicinal chemistry of synthetic and natural derivatives of cannabidiol","volume":"8","author":"Morales","year":"2017","journal-title":"Front Pharm. [Internet]"},{"issue":"10","key":"10.1016\/j.biopha.2023.115805_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/biom12101462","article-title":"Sex differences in the neuropsychiatric effects and pharmacokinetics of cannabidiol: a scoping review","volume":"12","author":"Matheson","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.biopha.2023.115805_bib32","doi-asserted-by":"crossref","DOI":"10.1007\/s11095-023-03469-1","article-title":"Cannabidiol for the treatment of brain disorders: therapeutic potential and routes of administration","author":"Yau","year":"2023","journal-title":"Pharm. Res."},{"key":"10.1016\/j.biopha.2023.115805_bib33","first-page":"1","article-title":"Cannabidiol: pharmacology and therapeutic targets","volume":"238","author":"Britch","year":"2020","journal-title":"Psychopharmacology"},{"issue":"10","key":"10.1016\/j.biopha.2023.115805_bib34","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.tips.2009.07.006","article-title":"Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb","volume":"30","author":"Izzo","year":"2009","journal-title":"Trends Pharm. Sci. [Internet]"},{"key":"10.1016\/j.biopha.2023.115805_bib35","doi-asserted-by":"crossref","first-page":"5186","DOI":"10.3390\/molecules25215186","article-title":"Molecular targets of cannabidiol in experimental models of neurological disease","volume":"25","author":"Silvestro","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2023.115805_bib36","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3390\/ph13090219","article-title":"Towards better delivery of cannabidiol (CBD)","volume":"13","author":"Millar","year":"2020","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.biopha.2023.115805_bib37","doi-asserted-by":"crossref","DOI":"10.1002\/ptr.7742","article-title":"Nanoformulations as a strategy to overcome the delivery limitations of cannabinoids","author":"Reddy","year":"2023","journal-title":"Phytother. Res."},{"issue":"6","key":"10.1016\/j.biopha.2023.115805_bib38","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1089\/can.2021.0176","article-title":"A randomized, triple-blind, comparator-controlled parallel study investigating the pharmacokinetics of cannabidiol and tetrahydrocannabinol in a novel delivery system, solutech, in Association with Cannabis Use History","volume":"7","author":"Berl","year":"2022","journal-title":"Cannabis Cannabinoid Res [Internet]"},{"key":"10.1016\/j.biopha.2023.115805_bib39","doi-asserted-by":"crossref","unstructured":"Moazen-Zadeh E., Chisholm A., Bachi K., Hurd Y.L. Pharmacokinetics of Cannabidiol: A systematic review and meta-regression analysis. medRxiv [Internet]. 2023 Feb 2 [cited 2023 Mar 19]; Available from: \u3008http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/36778355\u3009.","DOI":"10.1101\/2023.02.01.23285341"},{"key":"10.1016\/j.biopha.2023.115805_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2023.113799","article-title":"Review of the oral toxicity of cannabidiol (CBD)","volume":"176","author":"Gingrich","year":"2023","journal-title":"Food Chem. Toxicol."},{"issue":"1","key":"10.1016\/j.biopha.2023.115805_bib41","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1089\/can.2022.0100","article-title":"Cannabidiol safety data: a systematic mapping study","volume":"8","author":"Henderson","year":"2023","journal-title":"Cannabis Cannabinoid Res. [Internet]"},{"issue":"1","key":"10.1016\/j.biopha.2023.115805_bib42","first-page":"215","article-title":"The safety and effectiveness of commercially available cannabidiol products for health and well-being: a randomized, multi-arm, open-label waitlist-controlled trial","volume":"1","author":"Saleska","year":"2022","journal-title":"https:\/\/home. Liebe Com. \/imr [Internet"},{"issue":"4","key":"10.1016\/j.biopha.2023.115805_bib43","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1001\/jamapsychiatry.2019.4157","article-title":"Leading the next cbd wave\u2014safety and efficacy","volume":"77","author":"Hurd","year":"2020","journal-title":"JAMA Psychiatry [Internet]"},{"key":"10.1016\/j.biopha.2023.115805_bib44","unstructured":"Treves N., Mor N., Allegaert K., Bassalov H., Berkovitch M., Stolar O.E., et al. Efficacy and safety of medical cannabinoids in children: a systematic review and meta-analysis. Scientific Reports 2021 11:1 [Internet]. 2021 Dec 6 [cited 2023 Aug 3];11(1):1\u201311. Available from: \u3008https:\/\/www.nature.com\/articles\/s41598\u2013021-02770\u20136\u3009."},{"key":"10.1016\/j.biopha.2023.115805_bib45","doi-asserted-by":"crossref","first-page":"989","DOI":"10.3390\/jcm8070989","article-title":"Potential adverse drug events and drug\u2013drug interactions with medical and consumer cannabidiol (CBD) use","volume":"8","author":"Brown","year":"2019","journal-title":"J. Clin. Med."},{"issue":"4","key":"10.1016\/j.biopha.2023.115805_bib46","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1684\/epd.2020.1189","article-title":"Epidiolex-induced skin rash","volume":"22","author":"Singh","year":"2020","journal-title":"Epileptic Disord."},{"issue":"6","key":"10.1016\/j.biopha.2023.115805_bib47","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s40290-022-00446-8","article-title":"The effectiveness and safety of cannabidiol in non-seizure-related indications: a systematic review of published randomized clinical trials","volume":"36","author":"Tang","year":"2022","journal-title":"Pharm. Med. [Internet]"},{"key":"10.1016\/j.biopha.2023.115805_bib48","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.2147\/IJGM.S275049","article-title":"Safety considerations in cannabinoid-based medicine","volume":"13","author":"Gottschling","year":"2020","journal-title":"Int. J. Gen. Med. [Internet]"},{"issue":"1","key":"10.1016\/j.biopha.2023.115805_bib49","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/cts.13425","article-title":"The safety and efficacy of low oral doses of cannabidiol: an evaluation of the evidence","volume":"16","author":"Arnold","year":"2023","journal-title":"Clin. Transl. Sci. [Internet]"},{"issue":"12","key":"10.1016\/j.biopha.2023.115805_bib50","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1080\/17512433.2022.2142114","article-title":"Cannabidiol drug interaction considerations for prescribers and pharmacists","volume":"15","author":"Graham","year":"2022","journal-title":"Expert Rev. Clin. Pharm."},{"issue":"1","key":"10.1016\/j.biopha.2023.115805_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000528528","article-title":"CANNabinoid drug interaction review (CANN-DIR\u2122)","volume":"6","author":"Kocis","year":"2023","journal-title":"Med. Cannabis Cannabinoids [Internet]"},{"issue":"1","key":"10.1016\/j.biopha.2023.115805_bib52","first-page":"27","article-title":"Cannabidiol and \u03948-tetrahydrocannabinol: cannabinoids of rising interest and concern","volume":"35","author":"White","year":"2023","journal-title":"Forensic Sci. Rev."},{"issue":"12","key":"10.1016\/j.biopha.2023.115805_bib53","article-title":"Adverse effects of oral cannabidiol: an updated systematic review of randomized controlled trials (2020-2022)","volume":"14","author":"Souza","year":"2022","journal-title":"Pharmaceutics [Internet]"},{"issue":"S1","key":"10.1016\/j.biopha.2023.115805_bib54","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1684\/epd.2019.1125","article-title":"Adverse effects of cannabinoids","volume":"22","author":"Anciones","year":"2020","journal-title":"Epileptic Disord."},{"key":"10.1016\/j.biopha.2023.115805_bib55","doi-asserted-by":"crossref","DOI":"10.1111\/joim.13627","article-title":"Cannabidiol-associated hepatotoxicity: a systematic review and meta-analysis","author":"Lo","year":"2023","journal-title":"J. Intern Med. [Internet]"},{"issue":"6","key":"10.1016\/j.biopha.2023.115805_bib56","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s40290-022-00446-8","article-title":"The effectiveness and safety of cannabidiol in non-seizure-related indications: a systematic review of published randomized clinical trials","volume":"36","author":"Tang","year":"2022","journal-title":"Pharm. Med. [Internet]"},{"issue":"4","key":"10.1016\/j.biopha.2023.115805_bib57","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1021\/acs.chemrestox.3c00038","article-title":"Vaping Induced Cannabidiol (CBD) oxidation product CBD quinone forms protein adducts with KEAP1 and activates KEAP1-Nrf2 genes","volume":"36","author":"Love","year":"2023","journal-title":"Chem. Res. Toxicol. [Internet]"},{"issue":"4","key":"10.1016\/j.biopha.2023.115805_bib58","doi-asserted-by":"crossref","first-page":"237","DOI":"10.2174\/157488611798280924","article-title":"Safety and side effects of cannabidiol, a cannabis sativa constituent","volume":"6","author":"Machado Bergamaschi","year":"2011","journal-title":"Curr. Drug Saf."},{"issue":"1","key":"10.1016\/j.biopha.2023.115805_bib59","doi-asserted-by":"crossref","DOI":"10.1007\/s11657-022-01190-x","article-title":"Examining the role of cannabinoids on osteoporosis: a review","volume":"17","author":"Clouse","year":"2022","journal-title":"Arch. Osteoporos."},{"issue":"3","key":"10.1016\/j.biopha.2023.115805_bib60","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.3390\/molecules28031192","article-title":"Phytocannabinoids in the pharmacotherapy of psoriasis","volume":"28","author":"Wro\u0144ski","year":"2023","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.biopha.2023.115805_bib61","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/bcpt.13710","article-title":"A narrative review of molecular mechanism and therapeutic effect of cannabidiol (CBD)","volume":"130","author":"Peng","year":"2022","journal-title":"Basic Clin. Pharm. Toxicol. [Internet]"},{"issue":"10","key":"10.1016\/j.biopha.2023.115805_bib62","article-title":"Cannabidiol in dentistry: a scoping review","volume":"10","author":"David","year":"2022","journal-title":"Dent. J. (Basel) [Internet]"},{"key":"10.1016\/j.biopha.2023.115805_bib63","first-page":"12","article-title":"Cannabidiol as a novel therapeutic strategy for oral inflammatory diseases: a review of current knowledge and future perspectives","volume":"26","author":"Klein","year":"2020","journal-title":"Alter. Ther. Health Med."},{"key":"10.1016\/j.biopha.2023.115805_bib64","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.pharmthera.2017.02.041","article-title":"Cannabidiol: state of the art and new challenges for therapeutic applications","volume":"175","author":"Pisanti","year":"2017","journal-title":"Pharm. Ther."},{"issue":"12","key":"10.1016\/j.biopha.2023.115805_bib65","article-title":"Cannabinoids in Late Life Parkinson\u2019s disease and dementia: biological pathways and clinical challenges","volume":"12","author":"Costa","year":"2022","journal-title":"Brain Sci. [Internet]"},{"issue":"12","key":"10.1016\/j.biopha.2023.115805_bib66","article-title":"The gut microbiota in neurodegenerative diseases: revisiting possible therapeutic targets for cannabidiol","volume":"8","author":"Oliveira","year":"2022","journal-title":"Heliyon [Internet]"},{"issue":"12","key":"10.1016\/j.biopha.2023.115805_bib67","article-title":"Modulatory effect of gut microbiota on the gut-brain, gut-bone axes, and the impact of cannabinoids","volume":"12","author":"Ibrahim","year":"2022","journal-title":"Metabolites [Internet]"},{"issue":"3","key":"10.1016\/j.biopha.2023.115805_bib68","article-title":"Cannabinoids in the modulation of oxidative signaling","volume":"24","author":"Pagano","year":"2023","journal-title":"Int. J. Mol. Sci. [Internet]"},{"issue":"May","key":"10.1016\/j.biopha.2023.115805_bib69","article-title":"Cannabidiol as a promising strategy to treat and prevent movement disorders?","volume":"9","author":"Peres","year":"2018","journal-title":"Front Pharm."},{"key":"10.1016\/j.biopha.2023.115805_bib70","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.2147\/JIR.S355489","article-title":"The anti-inflammatory effects of cannabidiol (CBD) on acne","volume":"15","author":"Peyravian","year":"2022","journal-title":"J. Inflamm. Res [Internet]"},{"issue":"3","key":"10.1016\/j.biopha.2023.115805_bib71","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.clindermatol.2018.11.002","article-title":"The growing trend of cannabidiol in skincare products","volume":"37","author":"Jhawar","year":"2019","journal-title":"Clin. Dermatol."},{"issue":"21","key":"10.1016\/j.biopha.2023.115805_bib72","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232112956","article-title":"Role of cannabidiol for improvement of the quality of life in cancer patients: potential and challenges","volume":"23","author":"Green","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.biopha.2023.115805_bib73","doi-asserted-by":"crossref","first-page":"406","DOI":"10.52547\/ibj.3732","article-title":"Antitumorigenic effect of cannabidiol in lung cancer: what do we know so far?\u2013A mini review","volume":"26","author":"Vasileios","year":"2022","journal-title":"Iran. Biomed. J."},{"key":"10.1016\/j.biopha.2023.115805_bib74","article-title":"Cannabidiol regulates apoptosis and autophagy in inflammation and cancer: a review","volume":"14","author":"Fu","year":"2023","journal-title":"Front Pharm. [Internet]"},{"issue":"3","key":"10.1016\/j.biopha.2023.115805_bib75","article-title":"Drug-drug interactions of cannabidiol with standard-of-care chemotherapeutics","volume":"24","author":"Buchtova","year":"2023","journal-title":"Int. J. Mol. Sci. [Internet]"},{"issue":"6","key":"10.1016\/j.biopha.2023.115805_bib76","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1089\/can.2022.0220","article-title":"Molecular mechanisms through which cannabidiol may affect skeletal muscle metabolism, inflammation, tissue regeneration, and anabolism: a narrative review","volume":"7","author":"Schouten","year":"2022","journal-title":"Cannabis Cannabinoid Res."},{"issue":"9","key":"10.1016\/j.biopha.2023.115805_bib77","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1111\/imj.15724","article-title":"Cannabis, cannabidiol and tetrahydrocannabinol in sport: an overview","volume":"52","author":"Kennedy","year":"2022","journal-title":"Intern Med. J."},{"key":"10.1016\/j.biopha.2023.115805_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.prmcm.2023.100263","article-title":"Novel multi-target therapeutic potential of the genus Inula: advances and opportunities for neuroprotection","volume":"7","author":"Talebi","year":"2023","journal-title":"Pharmacol. Res. - Mod. Chin. Med."},{"issue":"19","key":"10.1016\/j.biopha.2023.115805_bib79","doi-asserted-by":"crossref","first-page":"3242","DOI":"10.1111\/bph.13724","article-title":"Cannabidiol regulation of emotion and emotional memory processing: relevance for treating anxiety-related and substance abuse disorders","volume":"174","author":"Lee","year":"2017","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.biopha.2023.115805_bib80","article-title":"Effects of cannabidiol (CBD) on regional cerebral blood flow","volume":"29","author":"De Souza Crippa","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopha.2023.115805_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.neubiorev.2022.104941","article-title":"Cannabinoid treatments for anxiety: a systematic review and consideration of the impact of sleep disturbance","volume":"143","author":"Narayan","year":"2022","journal-title":"Neurosci. Biobehav Rev."},{"issue":"November","key":"10.1016\/j.biopha.2023.115805_bib82","first-page":"454","article-title":"Cannabidiol regulation of learned fear: implications for treating anxiety-related disorders","volume":"7","author":"Jurkus","year":"2016","journal-title":"Front Pharm. [Internet]"},{"issue":"10","key":"10.1016\/j.biopha.2023.115805_bib83","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S2215-0366(20)30378-3","article-title":"Cannabidiol for cannabis use disorder: too high hopes?","volume":"7","author":"Hjorth\u00f8j","year":"2020","journal-title":"Lancet Psychiatry"},{"issue":"November","key":"10.1016\/j.biopha.2023.115805_bib84","first-page":"422","article-title":"Cannabidiol as a potential new type of an antipsychotic. a critical review of the evidence","volume":"7","author":"Rohleder","year":"2016","journal-title":"Front Pharm. [Internet]"},{"issue":"4","key":"10.1016\/j.biopha.2023.115805_bib85","first-page":"335","article-title":"Cannabidiol may help normalize brain function in psychosis","volume":"321","author":"Slomski","year":"2019","journal-title":"JAMA"},{"issue":"2\u20133","key":"10.1016\/j.biopha.2023.115805_bib86","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.schres.2016.06.022","article-title":"Does cannabidiol have a role in the treatment of schizophrenia?","volume":"176","author":"Gururajan","year":"2016","journal-title":"Schizophr. Res."},{"issue":"1","key":"10.1016\/j.biopha.2023.115805_bib87","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.euroneuro.2013.11.002","article-title":"Cannabidiol as a potential treatment for psychosis","volume":"24","author":"Schubart","year":"2014","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.biopha.2023.115805_bib88","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.phrs.2017.05.005","article-title":"Cannabidiol in medical marijuana: research vistas and potential opportunities","volume":"121","author":"Rong","year":"2017","journal-title":"Pharm. Res."},{"key":"10.1016\/j.biopha.2023.115805_bib89","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.lfs.2019.03.053","article-title":"Cannabidiol: recent advances and new insights for neuropsychiatric disorders treatment","volume":"224","author":"Premoli","year":"2019","journal-title":"Life Sci."},{"issue":"7","key":"10.1016\/j.biopha.2023.115805_bib90","first-page":"380","article-title":"Drop seizures cut by cannabidiol","volume":"14","author":"Ridler","year":"2018","journal-title":"Nat. Rev. Neurol."},{"issue":"10125","key":"10.1016\/j.biopha.2023.115805_bib91","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0140-6736(18)30136-3","article-title":"Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial","volume":"391","author":"Thiele","year":"2018","journal-title":"Lancet [Internet]"},{"issue":"3","key":"10.1016\/j.biopha.2023.115805_bib92","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S1474-4422(15)00379-8","article-title":"Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial","volume":"15","author":"Devinsky","year":"2016","journal-title":"Lancet Neurol. [Internet]"},{"key":"10.1016\/j.biopha.2023.115805_bib93","first-page":"33","article-title":"Cannabidiol as an intervention for addictive behaviors: a systematic review of the evidence","volume":"9","author":"Prud\u2019Homme","year":"2015","journal-title":"Subst. Abus. [Internet]"},{"key":"10.1016\/j.biopha.2023.115805_bib94","article-title":"Cannabidiol\u2019s neuroprotective properties and potential treatment of traumatic brain injuries","volume":"14","author":"Aychman","year":"2023","journal-title":"Front Neurol. [Internet]"},{"issue":"2","key":"10.1016\/j.biopha.2023.115805_bib95","article-title":"Cannabidiol: bridge between antioxidant effect, cellular protection, and cognitive and physical performance","volume":"12","author":"J\u00eetc\u0103","year":"2023","journal-title":"Antioxidants (Basel) [Internet]"},{"issue":"2","key":"10.1016\/j.biopha.2023.115805_bib96","article-title":"Endocannabinoid degradation enzyme inhibitors as potential antipsychotics: a medicinal chemistry perspective","volume":"11","author":"Mangiatordi","year":"2023","journal-title":"Biomed. [Internet]"},{"key":"10.1016\/j.biopha.2023.115805_bib97","doi-asserted-by":"crossref","DOI":"10.1007\/s11916-023-01101-w","article-title":"Medical cannabis for chronic nonmalignant pain management","author":"Hameed","year":"2023","journal-title":"Curr. Pain. Headache Rep. [Internet]"},{"issue":"1","key":"10.1016\/j.biopha.2023.115805_bib98","article-title":"The interplay between oxidative stress and autophagy: focus on the development of neurological diseases","volume":"18","author":"Talebi","year":"2022","journal-title":"Behav. Brain Funct. [Internet]"},{"issue":"Part B","key":"10.1016\/j.biopha.2023.115805_bib99","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.freeradbiomed.2015.06.006","article-title":"Molecular basis of the Keap1-Nrf2 system","volume":"88","author":"Suzuki","year":"2015","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.biopha.2023.115805_bib100","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.111214","article-title":"Curcumin and cardiovascular diseases: focus on cellular targets and cascades","volume":"136","author":"Pourbagher-Shahri","year":"2021","journal-title":"Biomed. Pharmacother."},{"issue":"13","key":"10.1016\/j.biopha.2023.115805_bib101","doi-asserted-by":"crossref","DOI":"10.1128\/MCB.00099-20","article-title":"The molecular mechanisms regulating the KEAP1-NRF2 pathway","volume":"40","author":"Baird","year":"2020","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.biopha.2023.115805_bib102","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1146\/annurev-pharmtox-010818-021856","article-title":"Modulating NRF2 in disease: timing is everything","volume":"59","author":"Dodson","year":"2019","journal-title":"Annu Rev. Pharm. Toxicol."},{"issue":"2","key":"10.1016\/j.biopha.2023.115805_bib103","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.bbadis.2016.11.005","article-title":"Nrf2 signaling pathway: pivotal roles in inflammation","volume":"1863","author":"Ahmed","year":"2017","journal-title":"Biochim Biophys. Acta Mol. Basis Dis."},{"issue":"5","key":"10.1016\/j.biopha.2023.115805_bib104","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.bbamcr.2018.02.010","article-title":"Nrf2-Keap1 signaling in oxidative and reductive stress","volume":"1865","author":"Bellezza","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"issue":"17","key":"10.1016\/j.biopha.2023.115805_bib105","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1089\/ars.2017.7342","article-title":"Transcriptional regulation by Nrf2","volume":"29","author":"Tonelli","year":"2018","journal-title":"Antioxid. Redox Signal"},{"issue":"13","key":"10.1016\/j.biopha.2023.115805_bib106","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms21134777","article-title":"NRF2, a transcription factor for stress response and beyond","volume":"21","author":"He","year":"2020","journal-title":"Int J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.biopha.2023.115805_bib107","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/carcin\/bgaa039","article-title":"NRF2 as a regulator of cell metabolism and inflammation in cancer","volume":"41","author":"He","year":"2020","journal-title":"Carcinogenesis"},{"issue":"4","key":"10.1016\/j.biopha.2023.115805_bib108","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1002\/ptr.6905","article-title":"Biological and therapeutic activities of thymoquinone: focus on the Nrf2 signaling pathway","volume":"35","author":"Talebi","year":"2021","journal-title":"Phytother. Res. [Internet]"},{"issue":"6","key":"10.1016\/j.biopha.2023.115805_bib109","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1002\/ptr.7033","article-title":"New insights into the role of the Nrf2 signaling pathway in green tea catechin applications","volume":"35","author":"Talebi","year":"2021","journal-title":"Phytother. Res. [Internet]"},{"key":"10.1016\/j.biopha.2023.115805_bib110","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s43450-022-00247-9","article-title":"Therapeutic effects of resveratrol in inflammatory bowel diseases: shedding light on the role of cellular and molecular pathways","volume":"32","author":"Talebi","year":"2022","journal-title":"Rev. Bras. De. Farmacogn."},{"issue":"4","key":"10.1016\/j.biopha.2023.115805_bib111","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1177\/2040622316653307","article-title":"Dimethyl fumarate in multiple sclerosis: latest developments, evidence and place in therapy","volume":"7","author":"Linker","year":"2016","journal-title":"Ther. Adv. Chronic Dis. [Internet]"},{"key":"10.1016\/j.biopha.2023.115805_bib112","doi-asserted-by":"crossref","first-page":"4778","DOI":"10.3390\/jcm11164778","article-title":"Efficacy and safety of dimethyl fumarate in patients with moderate-to-severe plaque psoriasis: DIMESKIN-2, a multicentre single-arm phase IIIb study","volume":"11","author":"Pellacani","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.biopha.2023.115805_bib113","article-title":"Activators and inhibitors of NRF2: a review of their potential for clinical development","volume":"2019","author":"Robledinos-Ant\u00f3n","year":"2019","journal-title":"Oxid. Med. Cell Longev. [Internet]"},{"issue":"6","key":"10.1016\/j.biopha.2023.115805_bib114","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1073\/pnas.89.6.2399","article-title":"A major inducer of anticarcinogenic protective enzymes from broccoli: isolation and elucidation of structure","volume":"89","author":"Zhang","year":"1992","journal-title":"Proc. Natl. Acad. Sci. [Internet]"},{"key":"10.1016\/j.biopha.2023.115805_bib115","doi-asserted-by":"crossref","first-page":"3593","DOI":"10.3390\/molecules24193593","article-title":"Broccoli or sulforaphane: is it the source or dose that matters?","volume":"24","author":"Yagishita","year":"2019","journal-title":"Molecules"},{"issue":"3","key":"10.1016\/j.biopha.2023.115805_bib116","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.tips.2022.12.003","article-title":"Advances and challenges in therapeutic targeting of NRF2","volume":"44","author":"Dinkova-Kostova","year":"2023","journal-title":"Trends Pharm. Sci. [Internet]"},{"issue":"1","key":"10.1016\/j.biopha.2023.115805_bib117","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/acn3.660","article-title":"Safety, pharmacodynamics, and potential benefit of omaveloxolone in Friedreich ataxia","volume":"6","author":"Lynch","year":"2019","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"2","key":"10.1016\/j.biopha.2023.115805_bib118","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/ana.25934","article-title":"Safety and efficacy of omaveloxolone in friedreich ataxia (MOXIe Study)","volume":"89","author":"Lynch","year":"2021","journal-title":"Ann. Neurol. [Internet]"},{"key":"10.1016\/j.biopha.2023.115805_bib119","first-page":"4","article-title":"Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases","volume":"18","author":"Cuadrado","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.biopha.2023.115805_bib120","article-title":"How do phytocannabinoids affect cardiovascular health? An update on the most common cardiovascular diseases","volume":"14","author":"Dziemitko","year":"2023","journal-title":"Ther. Adv. Chronic Dis. [Internet]"},{"key":"10.1016\/j.biopha.2023.115805_bib121","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2022.110079","article-title":"Protective effect and mechanism of cannabidiol on myocardial injury in exhaustive exercise training mice","volume":"365","author":"Zhang","year":"2022","journal-title":"Chem. Biol. Inter."},{"issue":"7","key":"10.1016\/j.biopha.2023.115805_bib122","doi-asserted-by":"crossref","DOI":"10.3390\/cells9071703","article-title":"Cannabidiol promotes endothelial cell survival by heme oxygenase-1-mediated autophagy","volume":"9","author":"B\u00f6ckmann","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.biopha.2023.115805_bib123","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/6647222","article-title":"Antioxidant and anti-inflammatory effect of cannabidiol contributes to the decreased lipid peroxidation of keratinocytes of rat skin exposed to UV radiation","volume":"2021","author":"Jastrz\u0105b","year":"2021","journal-title":"Oxid. Med Cell Longev."},{"key":"10.1016\/j.biopha.2023.115805_bib124","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2020.113656","article-title":"Therapeutic application of cannabidiol on UVA and UVB irradiated rat skin. A proteomic study","volume":"192","author":"Atalay","year":"2021","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"19","key":"10.1016\/j.biopha.2023.115805_bib125","article-title":"Photoprotective effects of cannabidiol against ultraviolet-B-induced DNA damage and autophagy in human keratinocyte cells and mouse skin tissue","volume":"27","author":"Li","year":"2022","journal-title":"Mol. [Internet]"},{"issue":"8","key":"10.1016\/j.biopha.2023.115805_bib126","doi-asserted-by":"crossref","DOI":"10.3390\/cells8080827","article-title":"Cannabidiol regulates the expression of keratinocyte proteins involved in the inflammation process through transcriptional regulation","volume":"8","author":"Jastrz\u0105b","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.biopha.2023.115805_bib127","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2019.101321","article-title":"Cannabidiol induces antioxidant pathways in keratinocytes by targeting BACH1","volume":"28","author":"Casares","year":"2020","journal-title":"Redox Biol."},{"key":"10.1016\/j.biopha.2023.115805_bib128","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdermsci.2023.01.008","article-title":"Cannabidiol mediates epidermal terminal differentiation and redox homeostasis through aryl hydrocarbon receptor (AhR)-dependent signaling","author":"Jang","year":"2023","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.biopha.2023.115805_bib129","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41574-019-0176-8","article-title":"Obesity: global epidemiology and pathogenesis","volume":"15","author":"Bl\u00fcher","year":"2019","journal-title":"Nat. Rev. Endocrinol."},{"issue":"5","key":"10.1016\/j.biopha.2023.115805_bib130","article-title":"Attenuation of oxidative stress and inflammatory response by chronic cannabidiol administration is associated with improved n-6\/n-3 PUFA ratio in the white and red skeletal muscle in a rat model of high-fat diet-induced obesity","volume":"13","author":"Bielawiec","year":"2021","journal-title":"Nutr. [Internet]"},{"issue":"5","key":"10.1016\/j.biopha.2023.115805_bib131","doi-asserted-by":"crossref","first-page":"520","DOI":"10.7150\/ijbs.8879","article-title":"Macrophage polarization in inflammatory diseases","volume":"10","author":"Liu","year":"2014","journal-title":"Int. J. Biol. Sci. [Internet]"},{"key":"10.1016\/j.biopha.2023.115805_bib132","first-page":"1","article-title":"Macrophage commonalities across tissues and inflammation","volume":"22","author":"Richter","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biopha.2023.115805_bib133","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.fitote.2016.05.008","article-title":"Anti-inflammatory and antioxidant effects of a combination of cannabidiol and moringin in LPS-stimulated macrophages","volume":"112","author":"Rajan","year":"2016","journal-title":"Fitoter. [Internet]"},{"key":"10.1016\/j.biopha.2023.115805_bib134","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-49835-1","article-title":"Pioglitazone attenuates kidney injury in an experimental model of gentamicin-induced nephrotoxicity in rats","volume":"9","author":"Medi\u0107","year":"2019","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.biopha.2023.115805_bib135","first-page":"343","article-title":"Cannabidiol interacts with the FXR\/Nrf2 pathway and changes the CB1\/CB2 receptors ratio in gentamicin-induced kidney injury in rats","volume":"26","author":"Hokmabadi","year":"2023","journal-title":"Iran. J. Basic Med Sci. [Internet]"},{"key":"10.1016\/j.biopha.2023.115805_bib136","article-title":"Pentosan polysulfate sodium for interstitial cystitis\/bladder pain syndrome?","author":"Allan","year":"2015","journal-title":"NEJM J. Watch [Internet]"},{"key":"10.1016\/j.biopha.2023.115805_bib137","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/nrurol.2012.217","article-title":"Intravesical treatments of bladder pain syndrome\/interstitial cystitis","volume":"9","author":"Neuhaus","year":"2012","journal-title":"Nat. Rev. Urol."},{"issue":"6","key":"10.1016\/j.biopha.2023.115805_bib138","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/iju.14229","article-title":"Interstitial cystitis\/bladder pain syndrome: the evolving landscape, animal models and future perspectives","volume":"27","author":"Akiyama","year":"2020","journal-title":"Int. J. Urol. [Internet]"},{"key":"10.1016\/j.biopha.2023.115805_bib139","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ebiom.2016.03.040","article-title":"Urinary metabolomics identifies a molecular correlate of interstitial cystitis\/bladder pain syndrome in a multidisciplinary approach to the study of chronic pelvic pain (MAPP) research network cohort","volume":"7","author":"Parker","year":"2016","journal-title":"EBioMedicine [Internet]"},{"issue":"5","key":"10.1016\/j.biopha.2023.115805_bib140","article-title":"Cannabidiol as a promising therapeutic option in ic\/bps: in vitro evaluation of its protective effects against inflammation and oxidative stress","volume":"24","author":"Kuret","year":"2023","journal-title":"Int. J. Mol. Sci. [Internet]"},{"key":"10.1016\/j.biopha.2023.115805_bib141","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.3390\/curroncol28020134","article-title":"Impact of metformin on cancer biomarkers in non-diabetic cancer patients: a systematic review and meta-analysis of clinical trials","volume":"28","author":"Farkhondeh","year":"2021","journal-title":"Curr. Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2023.115805_bib142","first-page":"17","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel Mph","year":"2023","journal-title":"CA Cancer J. Clin. [Internet"},{"issue":"5","key":"10.1016\/j.biopha.2023.115805_bib143","article-title":"Cannabidiol inhibits tumorigenesis in cisplatin-resistant non-small cell lung cancer via TRPV2","volume":"14","author":"Misri","year":"2022","journal-title":"Cancers (Basel) [Internet]"},{"issue":"1","key":"10.1016\/j.biopha.2023.115805_bib144","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2014.566","article-title":"Reactive oxygen species-mediated therapeutic response and resistance in glioblastoma","volume":"6","author":"Singer","year":"2015","journal-title":"Cell Death Dis."},{"issue":"3","key":"10.1016\/j.biopha.2023.115805_bib145","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/jcpt.12504","article-title":"Cannabidiol: an alternative therapeutic agent for oral mucositis?","volume":"42","author":"Cuba","year":"2017","journal-title":"J. Clin. Pharm. Ther."},{"issue":"15","key":"10.1016\/j.biopha.2023.115805_bib146","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1001\/jama.2019.3269","article-title":"The search for an effective therapy and pain relief for oral mucositis","volume":"321","author":"Elad","year":"2019","journal-title":"JAMA [Internet]"},{"issue":"9309","key":"10.1016\/j.biopha.2023.115805_bib147","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0140-6736(02)07960-6","article-title":"Management of oral mucositis associated with cancer chemotherapy","volume":"359","author":"Mead","year":"2002","journal-title":"Lancet [Internet]"},{"issue":"12","key":"10.1016\/j.biopha.2023.115805_bib148","article-title":"Alleviation of radiotherapy-induced oral mucositis","volume":"20","author":"Gourd","year":"2019","journal-title":"Lancet Oncol. [Internet]"},{"key":"10.1016\/j.biopha.2023.115805_bib149","article-title":"Protective effects of cannabidiol on chemotherapy-induced oral mucositis via the Nrf2\/Keap1\/ARE signaling pathways","volume":"2022","author":"Li","year":"2022","journal-title":"Oxid. Med. Cell Longev."},{"issue":"18","key":"10.1016\/j.biopha.2023.115805_bib150","article-title":"Disease-dependent antiapoptotic effects of cannabidiol for keratinocytes observed upon UV irradiation","volume":"22","author":"W\u00f3jcik","year":"2021","journal-title":"Int. J. Mol. Sci. [Internet]"},{"issue":"10360","key":"10.1016\/j.biopha.2023.115805_bib151","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/S0140-6736(22)01272-7","article-title":"Amyotrophic lateral sclerosis","volume":"400","author":"Feldman","year":"2022","journal-title":"Lancet [Internet]"},{"issue":"6435","key":"10.1016\/j.biopha.2023.115805_bib152","first-page":"89","article-title":"Spatiotemporal dynamics of molecular pathology in amyotrophic lateral sclerosis","volume":"364","author":"Maniatis","year":"2019","journal-title":"Science (1979) [Internet]"},{"issue":"11","key":"10.1016\/j.biopha.2023.115805_bib153","article-title":"Could the combination of two non-psychotropic cannabinoids counteract neuroinflammation? Effectiveness of cannabidiol associated with cannabigerol","volume":"55","author":"Mammana","year":"2019","journal-title":"Medicina (Lithuania)"},{"issue":"7","key":"10.1016\/j.biopha.2023.115805_bib154","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S1474-4422(22)00189-2","article-title":"Huntington\u2019s disease: disappointments and new beginnings","volume":"21","author":"Saft","year":"2022","journal-title":"Lancet Neurol. [Internet]"},{"issue":"7","key":"10.1016\/j.biopha.2023.115805_bib155","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/S1474-4422(22)00120-X","article-title":"A biological classification of Huntington\u2019s disease: the Integrated staging system","volume":"21","author":"Tabrizi","year":"2022","journal-title":"Lancet Neurol. [Internet]"},{"key":"10.1016\/j.biopha.2023.115805_bib156","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/s41582-020-0389-4","article-title":"Huntington disease: new insights into molecular pathogenesis and therapeutic opportunities","volume":"16","author":"Tabrizi","year":"2020","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.biopha.2023.115805_bib157","article-title":"Isomeric O-methyl cannabidiolquinones with dual BACH1\/NRF2 activity","volume":"37","author":"Casares","year":"2020","journal-title":"Redox Biol. [Internet]"},{"key":"10.1016\/j.biopha.2023.115805_bib158","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-021-90059-z","article-title":"Gene variants and expression changes of SIRT1 and SIRT6 in peripheral blood are associated with Parkinson\u2019s disease","volume":"11","author":"Maszlag-T\u00f6r\u00f6k","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2023.115805_bib159","article-title":"Cannabidiol induces autophagy to protects neural cells from mitochondrial dysfunction by upregulating SIRT1 to inhibits NF-\u03baB and NOTCH pathways","volume":"15","author":"Kang","year":"2021","journal-title":"Front Cell Neurosci. [Internet]"},{"issue":"4","key":"10.1016\/j.biopha.2023.115805_bib160","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","article-title":"Neuroinflammation in Alzheimer\u2019s disease","volume":"14","author":"Heneka","year":"2015","journal-title":"Lancet Neurol. [Internet]"},{"key":"10.1016\/j.biopha.2023.115805_bib161","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-022-02584-x","article-title":"Neuroinflammation represents a common theme amongst genetic and environmental risk factors for Alzheimer and Parkinson diseases","volume":"19","author":"Boyd","year":"2022","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.biopha.2023.115805_bib162","first-page":"3","article-title":"Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?","volume":"17","author":"Leng","year":"2020","journal-title":"Nat. Rev. Neurol."},{"issue":"274","key":"10.1016\/j.biopha.2023.115805_bib163","article-title":"Neuroinflammation: friend or foe?","volume":"7","author":"Musiek","year":"2015","journal-title":"Sci. Transl. Med [Internet]"},{"issue":"5","key":"10.1016\/j.biopha.2023.115805_bib164","doi-asserted-by":"crossref","first-page":"634","DOI":"10.2174\/2666796702666210709122407","article-title":"A concise overview of biosensing technologies for the detection of Alzheimer\u2019s disease biomarkers","volume":"23","author":"Talebi","year":"2021","journal-title":"Curr. Pharm. Biotechnol."},{"issue":"8","key":"10.1016\/j.biopha.2023.115805_bib165","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1056\/NEJMcibr1214546","article-title":"Neuroinflammatory cytokine signaling and Alzheimer\u2019s disease","volume":"368","author":"Griffin","year":"2013","journal-title":"N. Engl. J. Med. [Internet]"},{"issue":"2","key":"10.1016\/j.biopha.2023.115805_bib166","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0212039","article-title":"MiRNA expression profiles and molecular networks in resting and LPS-activated BV-2 microglia-effect of cannabinoids","volume":"14","author":"Juknat","year":"2019","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.biopha.2023.115805_bib167","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1111\/j.1476-5381.2011.01461.x","article-title":"Differential transcriptional profiles mediated by exposure to the cannabinoids cannabidiol and \u0394 9-tetrahydrocannabinol in BV-2 microglial cells","volume":"165","author":"Juknat","year":"2012","journal-title":"Br. J. Pharm."},{"issue":"4","key":"10.1016\/j.biopha.2023.115805_bib168","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0061462","article-title":"Microarray and pathway analysis reveal distinct mechanisms underlying cannabinoid-mediated modulation of LPS-induced activation of BV-2 microglial cells","volume":"8","author":"Juknat","year":"2013","journal-title":"PLoS One"},{"issue":"Suppl","key":"10.1016\/j.biopha.2023.115805_bib169","first-page":"93","article-title":"Schizophrenia induces oxidative stress and Cytochrome C release in isolated rat brain mitochondria: a possible pathway for induction of apoptosis and neurodegeneration","volume":"13","author":"Faizi","year":"2014","journal-title":"Iran. J. Pharm. Res. [Internet]"},{"issue":"5","key":"10.1016\/j.biopha.2023.115805_bib170","doi-asserted-by":"crossref","first-page":"e212","DOI":"10.1016\/S2468-2667(19)30054-4","article-title":"Towards a public health approach to psychotic disorders","volume":"4","author":"Anderson","year":"2019","journal-title":"Lancet Public Health [Internet]"},{"issue":"6","key":"10.1016\/j.biopha.2023.115805_bib171","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1007\/s12035-022-02800-y","article-title":"Inflammation and nitro-oxidative stress as drivers of endocannabinoid system aberrations in mood disorders and schizophrenia","volume":"59","author":"Morris","year":"2022","journal-title":"Mol. Neurobiol."},{"issue":"2","key":"10.1016\/j.biopha.2023.115805_bib172","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1056\/NEJMra1401483","article-title":"Multiple sclerosis","volume":"378","author":"Reich","year":"2018","journal-title":"N. Engl. J. Med. [Internet]"},{"issue":"6578","key":"10.1016\/j.biopha.2023.115805_bib173","first-page":"296","article-title":"Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis","volume":"375","author":"Bjornevik","year":"2022","journal-title":"Science (1979) [Internet]"},{"key":"10.1016\/j.biopha.2023.115805_bib174","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.neuroscience.2015.01.030","article-title":"Interaction between the protective effects of cannabidiol and palmitoylethanolamide in experimental model of multiple sclerosis in C57BL\/6 mice","volume":"290","author":"Rahimi","year":"2015","journal-title":"Neuroscience [Internet]"},{"issue":"6","key":"10.1016\/j.biopha.2023.115805_bib175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms22062992","article-title":"Cannabidiol and other cannabinoids in demyelinating diseases","volume":"22","author":"Navarrete","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2023.115805_bib176","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-016-0603-x","article-title":"Pathways and gene networks mediating the regulatory effects of cannabidiol, a nonpsychoactive cannabinoid, in autoimmune T cells","volume":"13","author":"Kozela","year":"2016","journal-title":"J. Neuroinflamm."},{"issue":"10","key":"10.1016\/j.biopha.2023.115805_bib177","article-title":"Pathomechanisms of paclitaxel-induced peripheral neuropathy","volume":"9","author":"Klein","year":"2021","journal-title":"Toxics [Internet]"},{"key":"10.1016\/j.biopha.2023.115805_bib178","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175288","article-title":"Mechanisms underlying paclitaxel-induced neuropathic pain: channels, inflammation and immune regulations","volume":"933","author":"Xu","year":"2022","journal-title":"Eur. J. Pharm."},{"key":"10.1016\/j.biopha.2023.115805_bib179","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.108693","article-title":"Role of cannabidiol and tetrahydrocannabivarin on Paclitaxel-induced neuropathic pain in rodents","volume":"107","author":"Kumar Kalvala","year":"2022","journal-title":"Int Immunopharmacol."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223016037?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223016037?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T21:27:10Z","timestamp":1779917230000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332223016037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":179,"alternative-id":["S0753332223016037"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115805","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic potentials of cannabidiol: Focus on the Nrf2 signaling pathway","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115805","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"115805"}}